| 000 | 01473 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516022612.0 | ||
| 264 | 0 | _c20110224 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a0019-4832 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKasliwal, Ravi R | |
| 245 | 0 | 0 |
_aRequirement of pharmacological treatment for primary prevention of cardiovascular disease in asymptomatic office-executives in north-India. _h[electronic resource] |
| 260 |
_bIndian heart journal _c |
||
| 300 |
_a324-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aIndia _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrimary Prevention |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aBansal, Manish | |
| 700 | 1 | _aMehrotra, Rahul | |
| 700 | 1 | _aAgrawal, Vinayak | |
| 700 | 1 | _aShrivastava, Sameer | |
| 773 | 0 |
_tIndian heart journal _gvol. 62 _gno. 4 _gp. 324-9 |
|
| 999 |
_c20559938 _d20559938 |
||